Cochlear Limited (ASX:COH)
309.03
+3.04 (0.99%)
Aug 15, 2025, 4:16 PM AEST
Cochlear Revenue
In the fiscal year ending June 30, 2025, Cochlear had annual revenue of 2.34B AUD with 4.81% growth. Cochlear had revenue of 1.17B in the half year ending June 30, 2025, with 11.46% growth.
Revenue
2.34B
Revenue Growth
+4.81%
P/S Ratio
8.63
Revenue / Employee
426.02K
Employees
5,097
Market Cap
20.21B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 2.34B | 107.50M | 4.81% |
Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 212.98M |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Mesoblast | 9.16M |
Regis Healthcare | 1.10B |
Cochlear News
- 1 day ago - Cochlear reports FY results - Seeking Alpha
- 1 day ago - Cochlear Ltd (CHEOF) (FY25) Earnings Call Highlights: Navigating Growth and Challenges - GuruFocus
- 1 day ago - Cochlear CEO depends on built-up inventory as some export licenses lag - CNBC
- 1 day ago - Full Year 2025 Cochlear Ltd Earnings Call Transcript - GuruFocus
- 1 day ago - Cochlear Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 1 day ago - Cochlear Limited (CHEOF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Cochlear tips higher earnings this year, slower first-half - The Australian Financial Review
- 1 day ago - ASX 200 LIVE: ASX to open modestly higher, results pending from Cochlear, Mirvac, US equities end little changed - The Australian Financial Review